Lunai Bioworks signs exclusive worldwide Tanaist collaboration for Parkinson’s platform

Lunai Bioworks announced an exclusive worldwide license and collaboration with Tanaist to add human cellular phenotyping to its AI-driven Parkinson’s program. Lunai will own collaboration-generated results and related IP under the agreement.